Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
alglucosidase alfa
alglucosidase alfa
Brand names: Myozyme
| Form | Strength |
|---|---|
| POWDER FOR INJECTION, INTRAVENOUS | 50 mg |
Last updated: Jan. 9, 2024
- Black Box Warning: Anaphylaxis; Cardiorespiratory Failure
- Restricted Restricted Medication
This medication is Inpatient Non-formulary and Restricted to Outpatient Use. Inpatient use requires approval by a physician department leader (ie Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.